Your browser doesn't support javascript.
loading
Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea.
Kim, Do Yeun; Ha, Hyerim; Bae, SeungJin; Kang, Jin Hyoung.
Affiliation
  • Kim DY; Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
  • Ha H; Department of Internal Medicine, Inha University Hospital, Incheon, Korea.
  • Bae S; Ewha Womans University, College of Pharmacy, Seoul, Korea.
  • Kang JH; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea. oncologykang@naver.com.
J Korean Med Sci ; 36(29): e191, 2021 Jul 26.
Article in En | MEDLINE | ID: mdl-34313033
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncologists / Medical Oncology / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Qualitative_research Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncologists / Medical Oncology / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Qualitative_research Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2021 Document type: Article Country of publication: